Model-based estimation of viral transmissibility and infection-induced resistance from the age-dependent prevalence of infection for 14 high-risk types of human papillomavirus.

scientific article published on 15 March 2010

Model-based estimation of viral transmissibility and infection-induced resistance from the age-dependent prevalence of infection for 14 high-risk types of human papillomavirus. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1093/AJE/KWP466
P8608Fatcat IDrelease_o5t5peen2fe3pbdvbvsk2gkcue
P698PubMed publication ID20231211

P50authorJacco WallingaQ30105749
Veerle M. CoupéQ73190157
Chris J L M MeijerQ90379336
P2093author name stringJohannes Berkhof
Johannes A Bogaards
Maria Xiridou
P433issue7
P407language of work or nameEnglishQ1860
P304page(s)817-825
P577publication date2010-03-15
P1433published inAmerican Journal of EpidemiologyQ4744243
P1476titleModel-based estimation of viral transmissibility and infection-induced resistance from the age-dependent prevalence of infection for 14 high-risk types of human papillomavirus
P478volume171

Reverse relations

cites work (P2860)
Q36106799A Bivariate Mixture Model for Natural Antibody Levels to Human Papillomavirus Types 16 and 18: Baseline Estimates for Monitoring the Herd Effects of Immunization
Q39604503Association between human papillomavirus vaccine uptake and cervical cancer screening in the Netherlands: implications for future impact on prevention
Q40301885Assortative mixing as a source of bias in epidemiological studies of sexually transmitted infections: the case of smoking and human papillomavirus.
Q35661925Bayesian time-series analysis of a repeated-measures poisson outcome with excess zeroes
Q39122093Bias Due to Correlation Between Times-at-Risk for Infection in Epidemiologic Studies Measuring Biological Interactions Between Sexually Transmitted Infections: A Case Study Using Human Papillomavirus Type Interactions
Q36843345Calibration of complex models through Bayesian evidence synthesis: a demonstration and tutorial
Q58085060Capturing sexual contact patterns in modelling the spread of sexually transmitted infections: Evidence using Natsal-3
Q38599579Different Challenges in Eliminating HPV16 Compared to Other Types: A Modeling Study
Q35596183Direct benefit of vaccinating boys along with girls against oncogenic human papillomavirus: bayesian evidence synthesis
Q92089108Estimated impact of human papillomavirus vaccines on infection burden: The effect of structural assumptions
Q45765408Exploring individual HPV coinfections is essential to predict HPV-vaccination impact on genotype distribution: a model-based approach
Q35463790Genital transmission of human papillomavirus in recently formed heterosexual couples
Q93054025Gini coefficients for measuring the distribution of sexually transmitted infections among individuals with different levels of sexual activity
Q40170982Health and Economic Impact of a Tender-Based, Sex-Neutral Human Papillomavirus 16/18 Vaccination Program in the Netherlands
Q41753413High-risk human papillomavirus in Galicia, Spain: prevalence and evaluation of the sample representativeness.
Q34462627Human papilloma virus vaccination programs reduce health inequity in most scenarios: a simulation study
Q47603242Impact of gender-neutral or girls-only vaccination against human papillomavirus-Results of a community-randomized clinical trial (I).
Q34979497Impact of vaccination on 14 high-risk HPV type infections: a mathematical modelling approach
Q51731914Impacts of human papillomavirus vaccination for different populations: A modelling study.
Q34490267Inference of type-specific HPV transmissibility, progression and clearance rates: a mathematical modelling approach
Q38673360Mechanistic mathematical models: An underused platform for HPV research
Q41933591Modeling of US Human Papillomavirus (HPV) Seroprevalence by Age and Sexual Behavior Indicates an Increasing Trend of HPV Infection Following the Sexual Revolution
Q47612436Modeling the consequences of regional heterogeneity in human papillomavirus (HPV) vaccination uptake on transmission in Switzerland
Q64091049Moving toward the elimination of cervical cancer: modelling the health and economic benefits of increasing uptake of human papillomavirus vaccines
Q51103584Naturally acquired immunity against human papillomavirus (HPV): why it matters in the HPV vaccine era.
Q36319941Optimizing technology for cervical cancer screening in high-resource settings
Q35166924Papillomaviruses: Viral evolution, cancer and evolutionary medicine
Q36597805Partner Human Papillomavirus Viral Load and Incident Human Papillomavirus Detection in Heterosexual Couples
Q38002182Prevalence and genotype distribution of cervical human papillomavirus infection among female sex workers in Asia: a systematic literature review and meta-analysis.
Q41611517Primary human papillomavirus DNA screening for cervical cancer prevention: Can the screening interval be safely extended?
Q34113476Sex-specific immunization for sexually transmitted infections such as human papillomavirus: insights from mathematical models
Q37016576The Melanoma MAICare Framework: A Microsimulation Model for the Assessment of Individualized Cancer Care
Q21296754The Strong Protective Effect of Circumcision against Cancer of the Penis
Q34583160The association of HPV-16 seropositivity and natural immunity to reinfection: insights from compartmental models
Q39704260The clinical benefit and cost-effectiveness of human papillomavirus vaccination for adult women in the Netherlands
Q101116336The cost-effectiveness profile of sex-neutral HPV immunisation in European tender-based settings: a model-based assessment
Q35038766The role of acquired immunity in the spread of human papillomavirus (HPV): explorations with a microsimulation model
Q37439328Type-specific human papillomavirus biological features: validated model-based estimates
Q36979148Updating the natural history of human papillomavirus and anogenital cancers
Q51773606Vaccination against human papillomavirus types 16 and 18: the impact on cervical cancer.

Search more.